{
    "eid": "2-s2.0-85143185374",
    "title": "An in Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "Nattarika Khuisangeam",
        "Sirirut Jewmoung",
        "Rattapoom Thaiwong",
        "Suparat Tudsamran",
        "Nattiya Hirankarn",
        "Koramit Suppipat",
        "Supannikar Tawinwung"
    ],
    "citedby-count": 1,
    "ref-count": 37,
    "ref-list": [
        "Cancer statistics, 2020",
        "Breast cancer survival and incidence: 10 years cancer registry data in the Northwest, Iran",
        "PSTAT3 expression associated with survival and mammographic density of breast cancer patients",
        "HER2-positive breast cancer patients: Correlation between mammographic and pathological findings",
        "Biological subtypes of breast cancer: Prognostic and therapeutic implications",
        "Immunotherapy: A challenge of breast cancer treatment",
        "Recent progress on immunotherapy for breast cancer: Tumor microenvironment, nanotechnology and more",
        "The application of CAR-T cell therapy in hematological malignancies: Advantages and challenges",
        "Expression of tumour-associated MUC1 is a poor prognostic marker in breast cancer in Kumasi, Ghana",
        "MUC1: A multifaceted oncoprotein with a key role in cancer progression",
        "The role of the cell surface mucin MUC1 as a barrier to infection and regulator of inflammation",
        "MUC1 alters oncogenic events and transcription in human breast cancer cells",
        "MUC1-C oncoprotein as a target in breast cancer: Activation of signaling pathways and therapeutic approaches",
        "MUC1 is a novel regulator of ErbB1 receptor trafficking",
        "An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas",
        "Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity",
        "CAR T cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth",
        "A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains",
        "Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor",
        "Multiomic analysis of cytokines in immuno-oncology",
        "Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy",
        "Selecting costimulatory domains for chimeric antigen receptors: Functional and clinical considerations",
        "4-1BB costimulation promotes CAR T cell survival through noncanonical NF- \u03ba B signaling",
        "4-1BB signaling beyond T cells",
        "Chimeric antigen receptor T cell persistence and memory cell formation",
        "Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells",
        "Parallel comparison of 4-1BB or CD28 co-stimulated CD19-targeted CAR-T cells for B cell non-Hodgkin's lymphoma",
        "Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28 \u03b6 T cells",
        "PSMA-directed CAR T cells combined with low-dose docetaxel treatment induce tumor regression in a prostate cancer xenograft model",
        "Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells",
        "Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy _in vivo_",
        "T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition",
        "Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric antigen receptor T cells",
        "CAR T cell therapy for breast cancer: Harnessing the tumor milieu to drive T cell activation",
        "Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199584",
            "affilname": "Chulalongkorn Cancer Immunotherapy Excellence Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}